SCHEMBL23313765

SCHEMBL23313765

c1ccc(-c2cc(-c3cccc4c3sc3ccccc34)cc(N(c3ccc(-c4ccccc4-c4ccccc4)cc3)c3ccc4sc5ccccc5c4c3)c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.45
PRKDC P78527 3/20 0.34
PARP14 Q460N5 1/20 0.33
TNKS O95271 1/20 0.33
TNKS2 Q9H2K2 1/20 0.33
F9 P00740 1/20 0.33
LIMK1 P53667 2/20 0.32
GPR3 P46089 1/20 0.31
PIM3 Q86V86 1/20 0.31
SLC9A1 P19634 1/20 0.30
PTGIR P43119 1/20 0.30
PIK3CD O00329 1/20 0.30
BRD4 O60885 1/20 0.30
PIK3CA P42336 1/20 0.30
PIK3CB P42338 1/20 0.30
MTOR P42345 1/20 0.30
PIK3CG P48736 1/20 0.30
KCNH2 Q12809 1/20 0.30
BRDT Q58F21 1/20 0.30
CYP1A2 P05177 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23313328 0.98 ALOX5 (0.47) ALOX5PRKDCPARP14TNKSTNKS2
SCHEMBL23313763 0.98 ALOX5 (0.47) ALOX5PRKDCPARP14TNKSTNKS2
SCHEMBL12960052 0.95 ALOX5 (0.49) ALOX5PRKDCPARP14TNKSTNKS2
SCHEMBL23313343 0.94 ALOX5 (0.42) ALOX5PRKDCPARP14TNKSTNKS2
SCHEMBL23313478 0.93 ALOX5 (0.45) ALOX5PRKDCPARP14TNKSTNKS2
SCHEMBL18802565 0.93 ALOX5 (0.47) ALOX5PRKDCPARP14TNKSTNKS2
SCHEMBL15964380 0.93 ALOX5 (0.51) ALOX5PRKDCPARP14TNKSTNKS2
SCHEMBL15964384 0.93 ALOX5 (0.51) ALOX5PRKDCPARP14TNKSTNKS2
SCHEMBL12283342 0.93 ALOX5 (0.51) ALOX5PRKDCPARP14TNKSTNKS2
SCHEMBL12959958 0.92 ALOX5 (0.52) ALOX5PRKDCPARP14TNKSTNKS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210126197-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND AMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2021-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210126197-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND AMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE PIEZO1, L1CAM, AOC1 ALOX5 1383/4885PRKDC 3926/4885PARP14 1894/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.